Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate
Amphetamine Aspartate Monohydrate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate
3 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 11 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 8 | SUPPLYING |
| Rhodes Pharmaceuticals LLC | unknown | 7 | SUPPLYING |
| Sandoz Inc | unknown | 4 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Oct 12, 2022SHORTAGEDrug shortage: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet (Sandoz Inc.)
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet — reported in shortage by Sandoz Inc.. Therapeutic category: Psychiatry.
Pill